Nutrigenomics Market Size, Share, Latest Insights, Analysis and Forecast 2026-2034

According to IMARC Group, the global Nutrigenomics Market Size reached USD 1,474.1 Million in 2025 and is projected to reach USD 3,348.9 Million by 2034, growing at a CAGR of 9.26% during 2026–2034. This strong Nutrigenomics Market Growth is driven by rising consumer awareness of gene–diet interactions, rapid advances in genetic testing technology, expanding applications in chronic disease management, and an accelerating shift toward precision and preventive healthcare globally.

Nutrigenomics Market Overview

Nutrigenomics sits at the intersection of genomics, molecular nutrition, and personalised medicine. It examines how dietary components influence gene expression, how genetic variation modulates nutrient metabolism, and how these interactions shape individual disease risk. The discipline enables clinicians, dieticians, and wellness practitioners to move beyond population-level dietary guidelines toward evidence-based, genetically-informed nutrition strategies.

A comprehensive Nutrigenomics Market Analysis reveals applications spanning four core clinical and wellness domains:

• Cardiovascular disease risk reduction through gene-specific dietary interventions

• Obesity management via genetic profiling of metabolism and appetite regulation

• Cancer risk stratification and nutrition-based prevention strategies

• Athletic performance optimisation through sport-specific nutrigenomic profiling

• Corporate employee wellness programmes with genetic nutrition screening

Global Nutrigenomics Market Size & Key Statistics

Below are the key Nutrigenomics Market statistics drawn from IMARC Group's comprehensive market analysis:

Base Year - 2025

Historical Period - 2020–2025

Forecast Period - 2026–2034

Nutrigenomics Market Size in 2025 - USD 1,474.1 Million

Market Forecast in 2034 - USD 3,348.9 Million

Market Growth Rate (2026–2034) - 9.26% CAGR

Largest Region - North America

Fastest Growing Region - Asia Pacific

Leading Product Segment - Reagents and Kits

Leading Application - Cardiovascular Diseases

Key Market Drivers & Nutrigenomics Market Trends in 2026

Several powerful forces are shaping the Nutrigenomics Market Trends and fuelling sustained double-digit growth across global health and wellness markets:

1. Growing Demand for Personalised Nutrition Solutions

Nutrigenomics is increasingly used to create personalised diets based on an individual's genetic makeup, helping to optimise health and prevent disease. This approach shifts away from generalised one-size-fits-all nutrition plans, offering tailored solutions that align with unique biological needs for better health outcomes. For instance, in August 2024, Avesthagen and Apollo AyurVAID partnered to launch 'AvestaAyurVAID,' integrating Ayurveda with nutrigenomics to create personalised medical foods and dietary supplements targeting specific nutritional needs for chronic diseases.

2. Integration of AI and Genetic Data Analytics

The combination of artificial intelligence and genetic analysis is enabling more accurate and actionable nutritional recommendations. AI helps decode complex gene–diet interactions by analysing large genomic datasets, enabling more precise dietary interventions for improving individual health. In July 2024, Vieroots Wellness Solutions introduced the EPLIMO programme, combining AI and genetic science to offer personalised wellness plans based on nutrigenomics, using genetic data to recommend diet, supplements, and lifestyle modifications to reduce disease risks.

3. Expanded Focus on Chronic Disease Management

Nutrigenomics plays an increasingly critical role in managing chronic conditions by offering targeted nutrition plans that can mitigate disease risks. Personalised diets are becoming a key tool in addressing diabetes, cardiovascular disease, and obesity. A notable Nutrigenomics Market Trend is the GENEY programme launched in August 2024, which promotes precision nutrition among youth by integrating genetic insights with dietary education to address obesity and non-communicable diseases in schools.

4. Rising Availability of Direct-to-Consumer Genetic Testing

The proliferation of direct-to-consumer (DTC) genetic testing services has significantly expanded the addressable market for nutrigenomics. Companies such as Nutrigenomix and Xcode Life are offering accessible, affordable genetic tests that provide actionable dietary guidance democratising personalised nutrition beyond clinical settings into everyday consumer wellness.

5. Corporate Wellness Programme Adoption

Employers are increasingly investing in genetic-based nutrition programmes as part of employee wellness strategies. Corporate nutrigenomics programmes reduce healthcare costs, improve workforce productivity, and enhance employee retention — creating a fast-growing institutional end-user segment that is reshaping the Nutrigenomics Market Share distribution across end-user categories.

6. Increasing Research & Development Investment

Strong R&D activity continues to expand the evidence base for nutrigenomics. The annual NuGO Week Conference — held in April 2024 in Italy — brought together global researchers to discuss the latest advances in nutrigenomics and personalised nutrition, highlighting how genetic insights are increasingly shaping mainstream dietary recommendations and clinical protocols.

7. Technological Advances in Genetic Sequencing and Bioinformatics

Declining costs of next-generation sequencing (NGS) and advances in bioinformatics platforms are making comprehensive genetic profiling faster, cheaper, and more clinically actionable. These technological improvements are directly expanding the Nutrigenomics Market Size addressable opportunity — particularly in emerging markets where cost has historically been a barrier.

Key Market Segmentation

By Product

Reagents and Kits – Largest Segment: Reagents and kits dominate the product segment as the consumable backbone of every nutrigenomic test, creating a recurring revenue stream that scales with test volume. These products support genetic testing and analysis workflows, helping identify gene–diet interactions and enabling tailored dietary recommendations. Leading suppliers include BASF SE, Koninklijke DSM N.V., and Thermo Fisher Scientific, whose reagent portfolios underpin both clinical laboratory and DTC testing channels.

Services: The services segment captures genetic profiling, data interpretation, and personalised wellness plan delivery. As nutrigenomics moves further into clinical practice and corporate wellness, demand for end-to-end managed services — from sample collection through actionable reporting — is expanding rapidly, supporting this segment's strong growth trajectory.

By Sample Type

Saliva – Dominant Non-Invasive Method: Saliva is the preferred sample type for DTC nutrigenomics testing due to its non-invasive collection, ease of transport, and consumer acceptability. Its dominance in the DTC channel makes it the most widely used sample type by volume.

Buccal Swab: Buccal swabs offer an alternative non-invasive collection method, widely used in clinical and corporate wellness settings for its simplicity and reliability.

Blood: Blood samples provide more detailed and comprehensive genomic information, preferred in advanced clinical nutrigenomics applications where depth of genetic analysis is prioritised over convenience.

Others: Includes urine and hair follicle samples used in specialised research and clinical protocols.

By Application

Cardiovascular Diseases – Largest Application: Cardiovascular disease risk management is the leading application, reflecting the well-established gene–diet interactions influencing lipid metabolism, blood pressure regulation, and inflammation pathways. Nutrigenomic profiling enables clinicians to prescribe heart-protective diets targeting an individual's specific genetic vulnerabilities.

Obesity: Genetic profiling of metabolism, appetite regulation, and fat storage pathways is enabling more effective, personalised weight management programmes — addressing the global obesity epidemic through science-based dietary precision.

Cancer Research: Nutrigenomics is informing cancer prevention strategies through dietary modulation of gene expression pathways associated with tumour initiation and progression.

Others: Includes diabetes management, sports performance, cognitive health, and reproductive health applications.

By End User

Dieticians – Core Clinical Channel: Dieticians are the primary clinical adopters of nutrigenomic testing, integrating genetic insights into personalised dietary counselling for chronic disease management, weight optimisation, and preventive health — significantly enhancing clinical outcomes compared to conventional nutritional guidance.

Sport Clinics: Sport clinics leverage nutrigenomics to optimise athlete performance, recovery, and injury prevention through genetically tailored nutrition and supplementation strategies — a rapidly growing segment within elite and recreational sports.

Corporate Programs: Employers are increasingly deploying nutrigenomics-based wellness programmes to optimise workforce health, reduce absenteeism, and lower long-term healthcare costs.

Others: Includes hospitals, academic research centres, and direct-to-consumer wellness platforms.

Regional Nutrigenomics Market Analysis

North America – Largest

United States & Canada; advanced healthcare infrastructure, high DTC genetic testing adoption, strong payer and employer wellness programme investment, leading companies (Nutrigenomix, Metagenics)

Europe

Germany, France, UK, Italy, Spain; strong genetic research investment, IVDR regulatory framework, NuGO research network, personalized nutrition policy initiatives

Asia Pacific – Fastest Growing

China, Japan, India, South Korea, Australia; rising health awareness, growing disposable incomes, expanding digital health platforms, increasing consumer inclination toward health and fitness

Latin America

Brazil, Mexico; extensive R&D activities, growing wellness market, Brazil largest LatAm healthcare market, expanding DTC testing access

Middle East & Africa

UAE, Saudi Arabia, South Africa; rising obesity rates, healthcare modernisation investment, growing demand for preventive nutrition solutions

North America leads the global Nutrigenomics Market Share, underpinned by a mature genetic testing ecosystem, high consumer willingness to invest in personalised health, and a well-established corporate wellness industry. The United States is the anchor market, home to pioneering companies such as Nutrigenomix and Metagenics.

Asia Pacific represents the fastest-growing regional market, propelled by rapidly rising health awareness, growing middle-class disposable incomes, and increasing government and private investment in digital health and precision medicine infrastructure — particularly in China, Japan, and India.

Leading Players in the Nutrigenomics Industry

The global nutrigenomics market features both diversified life sciences multinationals and focused pure-play nutrigenomics specialists. Key companies covered in the IMARC Group report include:

• BASF SE
• Cell-Logic
• Cura Integrative Medicine
• Danone S.A
• Fagron
• Genova Diagnostics
• Holistic Health International
• Koninklijke DSM N.V.
• Metagenics Inc.
• Nutrigenomix Inc.
• Xcode Life

About Us

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Healthcare, Technology, Food & Beverages, Chemicals, Energy, and more.

Contact Us

IMARC Group

United States: +1-201-971-6302

India: +91-120-433-0800

United Kingdom: +44-753-714-6104

Article source: https://article-realm.com/article/Business/84485-Nutrigenomics-Market-Size-Share-Latest-Insights-Analysis-and-Forecast-2026-2034.html